There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Astilbin is considered to be a new and promising immunosuppressant for immune related
diseases, but limited in clinical application due to its poor water solubility, difficult
oral absorption and low bioavailability.